Dupilumab Subcutaneous and Ethacrynic Sodium
Determining the interaction of Dupilumab Subcutaneous and Ethacrynic Sodium and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dupilumab
Brand name: Dupixent
Synonyms: Dupilumab
Generic Name: ethacrynic acid
Brand name: Edecrin, Edecrin Sodium, Sodium Edecrin
Synonyms: Ethacrynic acid, Ethacrynic Acid
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dupilumab Subcutaneous-Ethacrynic Sodium Injection
- Dupilumab Subcutaneous-Ethambutol
- Dupilumab Subcutaneous-Ethambutol Hydrochloride
- Dupilumab Subcutaneous-Ethchlorvynol
- Dupilumab Subcutaneous-Ethinyl estradiol and desogestrel
- Dupilumab Subcutaneous-Ethinyl Estradiol and Drospirenone
- Ethacrynic Sodium-Dupixent
- Ethacrynic Sodium-Duplex T Topical
- Ethacrynic Sodium-Durachol
- Ethacrynic Sodium-Duraclon
- Ethacrynic Sodium-Duraclon injection
- Ethacrynic Sodium-Duraflu